Cancer Moonshot funds will help USC researchers reduce health disparities in cancer research
$18.5 million in funding from the Cancer Moonshot will help researchers at USC Norris Comprehensive Cancer Center close the gap in our understanding of colorectal cancer in Hispanic patients
Medical trials lead to important innovations that save lives. But some racial and ethnic groups are woefully underrepresented in such research studies, leaving unanswered questions about how diseases and treatments affect these populations.
“A major reason for this is that we have not done enough to understand how to engage with patients and communities to reveal the barriers and concerns and to create approaches that are sensitive and culturally appropriate,” said John Carpten, PhD, professor and chair of translational genomics at the Keck School of Medicine of USC, director of the Institute of Translational Genomics, associate director of basic sciences at USC Norris Comprehensive Cancer Center and the Royce and Mary Trotter Chair in Cancer Research.
With support from a five-year, $18.5 million grant from the National Cancer Institute (NCI), as part of the Cancer Moonshot, researchers at USC Norris Comprehensive Cancer Center are working to address these gaps. Carpten and Heinz-Josef Lenz, MD, FACP, professor of medicine, associate director of clinical research at USC Norris cancer center and J. Terrence Lanni Chair in Gastrointestinal Cancer Research, will lead these efforts under a new center, the University of Southern California Center for Optimization of Participant Engagement for Cancer Characterization (USC COPECC).
“Each cancer patient is unique, but what we learn from one helps others,” said David Wesley Craig, PhD, professor of translational genomics and co-director of the Institute of Translational Genomics. “Studying diverse populations is the next opportunity to new therapies, new approaches, and better diagnostics across the board.”
Congress passed the 21st Century Cures Act in December 2016, authorizing $1.8 billion in funding for the Cancer Moonshot over 7 years. USC COPECC is among five Research Centers and a Coordinating Center within the Cancer Moonshot Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network. The USC team will focus on improving our understanding of colorectal cancer in Hispanic patients by identifying new ways to engage patients in genomic research—the study of our genes and the role they play in diseases like cancer.
“There is a significant disparity in the knowledge that we have about the tumor landscape of colorectal cancer among Hispanics,” said Mariana Stern, PhD, professor of clinical population and public health sciences and urology, associate director of population science at USC Norris cancer center and the Ira Goodman Chair in Cancer Research. “This has implications for the development of new therapies that may specifically benefit Hispanic patients. Our study will help close this gap of knowledge in a significant way.”
Partnering with community-based health organizations, the researchers will develop and share culturally relevant educational materials that aim to empower patients and community members to make informed decisions about their health and become savvy consumers of the opportunities available to them.
READ FULL ARTICLE HERE